Eden Research (LON:EDEN) Stock Price Down 3.3% – Here’s What Happened

Eden Research plc (LON:EDEN) shares were down 3.3% during trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a market cap of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The stock has a 50 day simple moving average of GBX 3.88 and a two-hundred day simple moving average of GBX 3.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insider Activity at Eden Research

In related news, insider Alexander John Abrey purchased 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction on Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). 14.02% of the stock is owned by insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.